Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs PROCTER & GAMBLE HEALTH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA PROCTER & GAMBLE HEALTH ASTRAZENECA PHARMA/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 95.5 34.5 277.0% View Chart
P/BV x 22.7 10.5 215.8% View Chart
Dividend Yield % 0.3 2.0 14.9%  

Financials

 ASTRAZENECA PHARMA   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-23
PROCTER & GAMBLE HEALTH
Jun-23
ASTRAZENECA PHARMA/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs3,6205,366 67.5%   
Low Rs2,4383,883 62.8%   
Sales per share (Unadj.) Rs401.2740.7 54.2%  
Earnings per share (Unadj.) Rs39.7138.2 28.7%  
Cash flow per share (Unadj.) Rs46.2155.2 29.8%  
Dividends per share (Unadj.) Rs16.0095.00 16.8%  
Avg Dividend yield %0.52.1 25.7%  
Book value per share (Unadj.) Rs234.4447.6 52.4%  
Shares outstanding (eoy) m25.0016.60 150.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.56.2 120.9%   
Avg P/E ratio x76.333.5 228.0%  
P/CF ratio (eoy) x65.529.8 219.9%  
Price / Book Value ratio x12.910.3 125.1%  
Dividend payout %40.368.7 58.6%   
Avg Mkt Cap Rs m75,71876,761 98.6%   
No. of employees `000NANA-   
Total wages/salary Rs m2,5912,062 125.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,03012,296 81.6%  
Other income Rs m261184 141.9%   
Total revenues Rs m10,29112,480 82.5%   
Gross profit Rs m1,2493,247 38.5%  
Depreciation Rs m163281 57.9%   
Interest Rs m68 81.8%   
Profit before tax Rs m1,3413,142 42.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m348847 41.1%   
Profit after tax Rs m9932,295 43.3%  
Gross profit margin %12.526.4 47.2%  
Effective tax rate %26.027.0 96.3%   
Net profit margin %9.918.7 53.0%  
BALANCE SHEET DATA
Current assets Rs m9,35911,713 79.9%   
Current liabilities Rs m4,8446,791 71.3%   
Net working cap to sales %45.040.0 112.5%  
Current ratio x1.91.7 112.0%  
Inventory Days Days49263 18.8%  
Debtors Days Days39343 11.4%  
Net fixed assets Rs m2,06110,617 19.4%   
Share capital Rs m50166 30.1%   
"Free" reserves Rs m5,8117,265 80.0%   
Net worth Rs m5,8617,431 78.9%   
Long term debt Rs m00-   
Total assets Rs m11,42122,330 51.1%  
Interest coverage x213.9409.1 52.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.6 159.5%   
Return on assets %8.710.3 84.9%  
Return on equity %16.930.9 54.9%  
Return on capital %23.042.4 54.2%  
Exports to sales %00-   
Imports to sales %37.413.1 286.1%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m3,7471,605 233.4%   
Fx inflow Rs m6121,465 41.8%   
Fx outflow Rs m3,7471,605 233.4%   
Net fx Rs m-3,135-140 2,236.1%   
CASH FLOW
From Operations Rs m5832,360 24.7%  
From Investments Rs m181-215 -84.2%  
From Financial Activity Rs m-245-985 24.9%  
Net Cashflow Rs m5191,160 44.7%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 51.8 144.7%  
Indian inst/Mut Fund % 5.4 20.3 26.8%  
FIIs % 2.7 7.6 35.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 48.2 51.9%  
Shareholders   29,032 56,730 51.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs Procter & Gamble Health

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs Procter & Gamble Health Share Price Performance

Period ASTRAZENECA PHARMA Procter & Gamble Health S&P BSE HEALTHCARE
1-Day 0.01% -0.55% 1.18%
1-Month -3.61% -7.47% -0.75%
1-Year 59.20% -3.02% 61.82%
3-Year CAGR 20.50% -9.12% 18.16%
5-Year CAGR 22.18% 5.75% 19.79%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the Procter & Gamble Health share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of Procter & Gamble Health.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 16.0 per share. This amounted to a Dividend Payout ratio of 40.3%.

Procter & Gamble Health paid Rs 95.0, and its dividend payout ratio stood at 68.7%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of Procter & Gamble Health.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.